Wide angle of nurses' station in hospital.
Podcast

Shining a Light on the Sunshine Act and Transparency Requirements: Rules of the Road in Europe

November 19, 2026
Life sciences companies working with patient organizations, healthcare professionals, and organizations in Europe face transparency rules that vary by country. The Latham team breaks down France’s detailed regime and offers practical tips for handling disclosure obligations across the rest of Europe.

France requires pharmaceutical and medical device companies to publicly disclose their agreements with a broad range of healthcare beneficiaries, along with the payments and benefits they provide — no matter where the company is headquartered. In the second episode of our “Shining a Light on the Sunshine Act and Transparency Requirements” series, Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice, and Washington, D.C. counsel Nicole Liffrig Molife walk through the French transparency rules, including who must report, the wide range of healthcare beneficiaries covered, which agreements, benefits, and payments must be disclosed, and key reporting deadlines. They then take a quick tour of transparency requirements elsewhere in Europe, including the UK.

Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.

Apple-Podcast-Badge reduced

spotify-podcast-badge-blk-grn-250x60

Endnotes